Olson R, Jiang W, Liu M, Bergman A, et al. Treatment With Stereotactic Ablative Radiotherapy for Up to 5 Oligometastases in Patients With Cancer: Primary Toxic Effect Results of the Nonrandomized Phase 2 SABR-5 Clinical Trial. JAMA Oncol 2022;8:1644-1650.
PMID: 36173619